An%20Overview%20of%20Marshfield%20Clinic - PowerPoint PPT Presentation

About This Presentation
Title:

An%20Overview%20of%20Marshfield%20Clinic

Description:

An Overview of Marshfield Clinic s Research Program Exploring Opportunities for Collaboration in the Real World Dr. Humberto Vidaillet Director of Medical ... – PowerPoint PPT presentation

Number of Views:507
Avg rating:3.0/5.0
Slides: 51
Provided by: AmitAc
Category:

less

Transcript and Presenter's Notes

Title: An%20Overview%20of%20Marshfield%20Clinic


1
An Overview of Marshfield Clinics Research
Program Exploring Opportunities for
Collaborationin the Real World
  • Dr. Humberto Vidaillet
  • Director of Medical Research, Marshfield Clinic
  • Director, Marshfield Clinic Research Foundation
  • Clinical Professor of Medicine, UW SMPH
  • September 14, 2011

2
Objectives Purpose of Forum
  • Provide an opportunity for research networks and
    other research groups to learn about each other
    and the projects they conduct.
  • Learn about operational and project barriers, and
    successful methods to overcome barriers.
  • Facilitate networking and connections between
    people and groups with similar interests.

3
Welcome to Marshfield Clinic
Ranked by Forbes in 2010 as the 5th best small
city in the country to raise a family.
Designated in 2008 by Demographics Daily as one
of the nations top 20 Dream Towns
4
Marshfield Clinic
  • Mission To serve patients through
    accessible, high quality health care,

    research and education
  • 501(c)(3) organization
  • Largest private group practice in WI
  • 52 centers in gt35 communities
  • gt770 physicians (102 family practice
  • physicians) in gt85 specialties
  • 6,600 additional personnel
  • 3.5 million patient encounters/year
    365,000 unique
    patients/year
  • Marshfield Labs (Human Veterinary)
  • Lakeview Medical Center, Rice Lake, WI
  • Security Health Plan (HMO)

5
Why Marshfield Clinic Engages in Research
Education
  • Core elements of Marshfield Clinics Mission, its
    status as a nationally recognized Academic
    Medical Center, and its Charitable Trust
  • Contribute to knowledge leading to advances in
    patient care, quality metrics and public health,
    improves the quality of human existence and the
    lives of our patients and their loved ones
  • Contribute to recruitment of high quality
    physicians and other professionals who want to
    work in an academic environment
  • Differentiate Marshfield Clinic from competitors
    patients rightly conclude that care is better at
    centers involved in research education
  • For clinicians who do research and teach, it adds
    another dimension to their contributions to
    medicine and improves their clinical practice
    for virtually all Marshfield Clinic employees, a
    sense of shared pride!
  • Research and Education have been integral to the
  • Clinics culture, sustained growth and quality of
    care since 1916!

6
Research Program at Marshfield Clinic
  • 400 active studies
  • 125-150 clinical investigators and 30 MD/PhD
    scientists
  • Major external sponsors NIH, CDC, NIOSH, AHRQ,
    Industry, Philanthropy
  • Academic structure IRB, Research Comm.,
    Research Compliance, Conflict of
    Interest, Biosafety, etc.
  • Tenure program and Endowed positions
  • Marshfield Clinic Research Foundation (MCRF)
  • Mission To discover and communicate scientific
    knowledge that substantially improves human
    health and well-being
  • - 200 staff

7
Research Program Structure
8
MCRF Board of Trustees
Oversees MCRF, providing policy direction,
financial oversight, and counsel to MCRF
leadership in a wide range of areas associated
with research structure, process, and resources
  • Physician Members
  • Jaime Boero, MD. Vice - Chair
  • Michael Caldwell, MD, PhD
  • Christopher Cold, MD
  • Rezwan Islam, MD
  • Ram Pathak, MD
  • Kent Ray, DO
  • Shereif Rezkalla, MD, Treasurer
  • Karl Ulrich, MD
  • Matthias Weiss, MD
  • Scientist Member
  • Po-Huang Chyou, Ph.D.
  • Community Members
  • Rene Daniels
  • John Hutchinson
  • Brian Kief
  • Patricia Kleine, Ph.D.
  • John Laird
  • Scott Larson, Secretary
  • Mark T. Nelson
  • Mark Nook, Ph.D., Chair
  • Jim Schuh
  • James Weber, PhD

Mark Nook, PhD
UW System, Interim Senior Vice President for
Academic Affairs
9
Other Capacities
  • Publish Clinical Medicine Research
  • Publish Journal of Agromedicine
  • With Division of Lab Medicine, part of State
    Laboratory Response Network and CDCs Select
    Agent Program provide Laboratory Medicine
    facilities for its RD
  • With Clinic Information System, develop new
    clinical medical informatics tools

9
10
Research Strategy and Guiding Principles
  • Integration of research into clinical practice
    and clinical practice into research.
  • Collaboration with other top-tier medical
    centers, especially UWSMPH (now ICTR) and MCW.
  • Dedication to achieving excellence in
    translational research, which requires close
    collaboration among physicians and scientists to
    bring scientific advances into clinical care and
    public health.

11
Select Research Collaborations at MCRF (1)
12
Select Research Collaborations at MCRF (2)
13
Institute for Clinical and Translational Research
(ICTR)
  • Founded jointly in 2007 by UW and MC
  • Has become framework of strengthening research
    ties between the two institutions
  • Awarded a Clinical and Translational Science
    Award by NIH now waiting for renewal
  • Unprecedented level of collaboration
    14 funded pilot projects with UW-Madison
    investigators working together with 23 Clinic
    investigators from 16 different departments
  • Likely to impact Clinics clinical and
    translational research for decades

PARTNERSHIP Schools of Medicine and Public
Health Pharmacy Nursing Veterinary Medicine and
College of Engineering
14
Strength of the Marshfield Clinic - UW Research
PartnershipCollaboration Integration of
Administrative Activities
15
The Marshfield-UW Partnership
16
Wisconsin IRB Consortium (WIC)
Purpose Facilitate collaboration among member
institutions' Institutional Review Boards (IRBs)
in order to provide more effective and efficient
oversight of multi-site human subject research
protocols In Wisconsin and reduce costs and
duplication of effort among the Member
institutions and affiliated investigators. One
Agreement Allows any member institution to serve
as the IRB of record for another, eliminating
the need to draft individual, study-specific IRB
authorization agreements for each study
reviewed. WIC is in its development/pilot phase
,and as such, is limited to the following
participants Aurora Health Care IRB, Milwaukee
Marshfield Clinic IRB, Marshfield Medical
College of Wisconsin IRB, Milwaukee University
of Wisconsin-Madison Health Sciences IRB, Madison
17
Clinical Research Center
  • Established in 1998 to provide centralized
    research support for clinician-led research
    throughout system
  • Built on a strategy of integrating research and
    clinical practice
  • More than 350 active clinical trials
  • 125-150 clinician investigators
  • gt40 research coordinators and research nurses as
    well as other administrative support staff
  • Community Clinical Oncology Program (CCOP) is the
    longest-running clinical research project

18
Type-2 Translational Research
The Role of Pharmacist Evaluation in Asthma
  • Study Goal
  • To conduct a pilot test of a telepharmacy-based
    intervention to improve asthma control through
    medications and disease management in an
    underserved, rural patient population.
  • Aims
  • To assess the feasibility of providing a
    telepharmacy intervention
  • To determine whether a telepharmacy intervention
    is acceptable
  • To assess the interventions impact on patients
    asthma control, adherence to medications, and
    patient activation
  • To examine the facilitators and barriers
    associated with implementing the intervention.

Local PI Suzanne N. Havican, RN, RPh, BCPS
PI Henry N. Young, PhD UW Madison
19
Type-2 Translational Research Tailored Approach
to Genetic Counseling for Cystic Fibrosis Newborn
Screening A New Model
Received additional/outside funding
20
Type-2 Translational Research
  • Creating Healthy Workplaces An intervention to
    Improve Outcomes for Providers and Patients
  • Study Goal
  • Test the impact of a novel quality improvement
    strategy on care quality. The quality improvement
    intervention (QIIs) will create healthy
    workplaces by addressing adverse primary care
    work conditions (workflow, work control, and
    organizational culture).
  • Aims
  • Increase clinician and staff interest in
    participating in QIIs by addressing primary care
    work conditions
  • Improve care quality in hypertension and diabetes
    by improving work conditions
  • Improve clinician and staff satisfaction,
    decrease stress, and reduce intention to leave

Local PI Steven H. Yale, MD
21
Epidemiology Research Center
  • Consequential epidemiology focus on applied
    research questions that make a difference in the
    lives of people
  • Vaccine safety effectiveness
  • Antibiotic resistance
  • Cancer surveillance
  • Cardiovascular care and outcomes
  • Unique resources network collaborations
  • Marshfield Epidemiology Study Area (MESA)
  • HMO Research Network (HMORN)
  • Cancer Research Network (NCI)
  • Cardiovascular Disease Research Network (NHLBI)
  • Vaccine Safety Datalink (CDC)
  • In 2011, Dr. Laura Coleman joined as
    tenure-track scientist

22
Marshfield Epidemiologic Study Area (MESA)
  • Key Features
  • Defined geographic region (24 zip codes)
  • Nearly all residents choose to receive health
    care from Marshfield Clinic and affiliated
    hospitals
  • Dynamic cohort tracked since 1991
  • Links to sophisticated electronic medical record
    system and data warehouse archive
  • Low population mobility
  • High population coverage and health event
    capture, in MESA Central
  • 97 population coverage
  • 99 deaths captured
  • 95 hospitalizations captures
  • 90 outpatient visits captured

25,000 people
60,000 people
23
Marshfield Epidemiologic Study Area (MESA)
  • There are more than 25 active consults in the
    current year, with many early and mid-career
    stage recipients, including
  • a UW Shapiro scholar,
  • an ICTR scholar,
  • UW Population-Health students,
  • UW faculty and medical residents,
  • Marshfield faculty and medical residents.

24
Collaborations MESA
  • Goal To examine the actual mortality burden and
    rates of cardiovascular events among a rural
    population-based cohort of lupus patients

Mortality Cardiovascular Events Among
Rural Systemic Lupus Erythematosus Patients
25
HMO Research Network
  • Mission Use collective scientific capabilities
    to integrate research and practice for the
    improvement of health and health care among
    diverse populations.
  • Consortium of 16 HMO organizations
  • MCRF leveraged the MESA cohort and Security
    Health Plan enrollees to facilitate membership in
    the HMORN.
  • Focus is on cancer, cardiovascular disease,
    diabetes, genomics, vaccine safety, medical
    product surveillance, health care quality, and
    comparative effectiveness.
  • MCRF co-hosted the National HMORN meeting in
    2008, at which the NCRR Director was a plenary
    keynote speaker.
  • MCRF investigators are currently leading efforts
    on more than 20 active collaborative research
    projects within the HMORN.

26
Survey of the Health of Wisconsin
  • First statewide research survey to systematically
    gather data on health status and health
    disparities among Wisconsin adults.
  • Marshfield Clinic became the home of a new, third
    recruitment and enrollment center for SHOW,
    joining Madison (Middleton) and Milwaukee.
  • MCRF assists SHOW data collection, including
    face-to face interviews, self administered
    questionnaires, and physical exams.
  • In the first year of the MCRF, 30 scheduled weeks
    of rural Wisconsin data collection were completed
    in three months due to Marshfield Clinics
    presence in rural WI communities.
  • The data collected from SHOW will address
    critical and novel research questions to
    accelerate translation into evidence-based
    policies and health care practices, and improve
    health and reduce health disparities in Wisconsin.

27
Center for Human Genetics
  • A long history of important discoveries in human
    genetics (short tandem repeat polymorphisms,
    Marshfield linkage maps)
  • Mission To conduct translational research in
    medical genetics that substantially improves
    patient care
  • In 2009, recruited Dr. Murray Brilliant (Center
    Director, tenured Senior Research Scientist and
    James Weber Endowed Chair)
  • in 2010, recruited Dr. Steve Schrodi and

    Dr. Deana Cross as tenure-track scientists
  • In 2011, joint recruitment of Dr. Brautbar
  • Major programs and unique resources
  • Personalized Medicine Research Project (PMRP)
  • Wisconsin Genomics Initiative (WGI)
  • Electronic Medical Records and Genomics (eMERGE)
    Network

28
Personalized Medicine Research Project (PMRP)
  • In September 2002, Governor McCallum and the
    leadership of MC and MCRF announced enrollment of
    the first research subject
  • Initial funds State government (2 million),
    Federal government (800K), and Marshfield Clinic
    (1 million)
  • Ultimate Goal Translate genetic data into
    specific knowledge about disease that is
    clinically relevant will enhance patient care
  • Key Features
  • Nations largest population-based biobank
  • Stable population of approximately 20,000 adults
  • DNA, plasma and serum samples on each subject
  • Access to longitudinal electronic health record
  • 99 of PMRP cohort has agreed to be re-contacted
  • All genotyped for 50 medically relevant markers,
    5K high-density genotyped samples

29
PMRP Community Advisory Group
  • The Community Advisory Group (CAG) provides
    advice and guidance from the community
    perspective on the continued development,
    implementation and on-going operations of the
    Personalized Medicine Research Project

30
Ongoing Studies
  • Genetic Basis of Disease
  • Atrial fibrillation/flutter
  • Cataracts
  • Endometriosis
  • Hypertensive heart disease
  • Low HDL
  • Macular degeneration
  • Multiple sclerosis
  • Myocardial infarction
  • Obesity, genetics and risk of diabetes and
    abnormal lipids
  • Prostate cancer
  • Venousthromboembolism Dz.
  • Pharmacogenetics
  • Efficacy and safety of statins
  • Efficacy of metformin in patients with type II
    diabetes
  • Pharmacogenetics of tamoxifen for breast cancer
  • Pharmacogenetics underlying response to beta
    blockers in patients with glaucoma
  • Pharmacogenetics of warfarin metabolism
  • Sulfa hypersensitivity
  • ACE and angioedema

31
Wisconsin Genomics Initiative (WGI)
  • Announced by Governor Doyle in October 2008
  • Received 2 million in State FY10-11 budget
  • A historic collaboration of Wisconsins three
    academic medical centers and its major urban
    university created to advance predictive and
    personalized health care
  • Vision to be able to predict for individual
    patients in a clinical setting the risk of
    disease susceptibility and treatment response
    using the combined power of cutting edge genetic,
    phenotypic, and environmental analyses

32
Wisconsin Genomics Initiative
33
Building Accurate Predictive Models
  • Complex combinations of variables are required
    for accurate prediction
  • The more we know about individual patients,
    greater the probability of prediction

34
WGI Funded Demonstration Projects (1)
  • Integrating Genomic Data into a Computational
    Model for Improved Breast Cancer Diagnosis
  • PIs Elizabeth Burnside, MD4 David Page, PhD4
  • Collaborators Cathy McCarty, PhD, MPH1 Peggy
    Peissig, MBA1 Adedayo Onitilo, MD1
  • Improving the Predictive Modeling of Atrial
    Fibrillation/Flutter (AF/F) and Its Outcomes
  • PI Humberto Vidaillet, MD1
  • Collaborators Bess Berg, MS4 David Page, PhD4
    Peggy Peissig, MBA1 Percy Karanjia, MD1
  • Feasibility of Modular High Throughput Electronic
    Phenotyping
  • PI Peggy Peissig, MBA1
  • WGI Infrastructure Project Proposal Expand the
    Current Informatics Architecture in Order to
    Capitalize on the Available EMR and Genetic Data
  • PI Justin Starren, MD, PhD1
  • WGI Exome Sequencing to Identify Coding Variants
    for Myocardial Infarction
  • PI Ulrich Broeckel, MD2
  • Collaborators Cathy McCarty, PhD, MPH1 David
    Page, PhD4

1MCRF ? 2MCW ? 3UW-Milwaukee ? 4UWSMPH
35
WGI Funded Demonstration Projects (2)
  • Risk Modeling Post-Hospitalization
    Venousthromboembolism in a Population-Based
    Cohort
  • PI Steve Yale, MD1
  • Collaborators Mark Craven, PhD4 Deanna Cross,
    PhD1 Stephen Talsness, BA1 Peggy Peissig, MBA1
    Joseph Mazza, MD1
  • Sustained Community Engagement in Genetics and
    Genomics Research to Improve Health
    and to Increase Health Equity
  • PIs Aaron Buseh PhD, MPH3 Sandra Underwood,
    PhD, RN, FAAN 3
  • Development of a Predictive Algorithm for
    Age-related Macular Degeneration
  • PI Murray Brilliant, PhD1
  • Collaborators David Page, PhD4 Joe Carroll,
    PhD4 Cathy McCarty, PhD, MPH1 Gary Pesicka,
    MD1 Robert Valenzuela1
  • Investigation of Genomic Association Between
    Heart Failure Diabetes Mellitus
  • PI Nancy Sweitzer, MD, PhD4
  • Collaborators Cathy McCarty, PhD, MPH1 Orly
    Vardeny, PharmD4 Zhan Ye, PhD1
  • Membrane Metaloproteinase-9 Genotype and Aortic
    Aneurysm
  • PI Jay Yang, MD, PhD4
  • Collaborators Sijan Wang PhD4 Martha Wynn MD4
    Charles Acher, MD4 Peggy Peissig, MBA1 Ulrich
    Broeckel, MD2

1MCRF ? 2MCW ? 3UW-Milwaukee ? 4UWSMPH
36
WGI Project Development of a Predictive
Algorithm for Age-Related Macular Degeneration
37
WGI Project Sustained Community Engagement in
Genetics Genomic Research to Improve Health
to Increase Health Equity
  • Study Purpose
  • Determine effective ways to engage members of
    diverse urban communities in genetic and genomics
    research designed to improve health and achieve
    health equity.
  • Aims
  • Determine how characteristics of diverse ethnic,
    racial urban communities are related to their
    potential engagement in genetics and genomics
    research
  • Describe knowledge and attitudes of members of
    diverse ethnic, racial urban communities toward
    genetics and genomics research for health
  • Identify facilitators and barriers to sustained
    engagement of members of diverse ethnic, racial
    urban communities in genetics and genomics
    research for health.

38
Collaboration with UW Waisman Center
  • Genetic/Complex Disorders
  • 1) To estimate the prevalence of premutation of
    FMR1 using the Wisconsin longitudinal Study (WLS)
    cohort (PMRP in the Marshfield cohort
  • 2) To describe natural history of premutation
    into adulthood and into old age (18 through 70
    yrs.) with respect to family background, academic
    achievement, IQ, marital history, fertility,
    childbearing patterns, menopause, occupational
    stability, depression and anxiety, health and
    physical symptoms and cognition.
  • 3) To compare men and women with the premutation
    with a closely matched comparison group of WLS
    unaffected age peers. Because of the small size
    of the sample with the permutation, this will be
    an exploratory aim.

Marsha Seltzer, PhD Waisman Center
Murray H. Brilliant, PhD MCRF
39
Marshfield Clinic Cataracts
Northwestern Type II diabetes
Group Health Cooperative Dementia
Coordinating center
Mayo Clinic Peripheral artery disease
Vanderbilt QRS duration
40
MCRFs Oral Systemic Health Research Project (1)
  • Goals
  • Understand the causes of oral diseases, such as
    periodontal disease and caries (e.g., determining
    the effect of genetics, diet, water source
    well/city fluoridation, and microbiome).
  • Understand the connections between oral and
    systemic health, (e.g., mutual enhancement of
    periodontal disease and diabetes).
  • Understand how improving oral health aids
    systemic health (comparative effectiveness) and
    bring PHC to the dental arena.

41
MCRFs Oral Systemic Health Research Project (2)
  • Microbiome contribution to heath is an NIH
    priority and our investigators will be among the
    first to utilize oral microbiome data in
    personalized healthcare
  • Will create a unique research infrastructure to
    support the OSHRP
  • Initial cohort of 2,000 participants with
    electronic dental and health records coupled with
    a comprehensive biobank (DNA, plasma, serum,
    urine and periodontal microbiome)
  • Questionnaire data on environment, diet, etc
  • OSHRP builds upon the Personalized Medicine
    Research Project (PMRP)
  • gt1,000 participants in PMRP who are also dental
    patients of Marshfield Clinic
    2 MC dental
    facilities in PMRP recruitment area have been
    operating for 1 year
  • As the Clinics Electronic Health Record
    contains medical and dental care information,
    this research sub-cohort of PMRP can be used
    today to study the connections between oral and
    systemic health in a population-based cohort
  • National Institute of Dental and Craniofacial
    Research (NIDCR) Collaborative Grant Data
    Extraction using Electronic Dental Record in
    Dental Practice Based Research Network
  • Collaborating with University of Pittsburgh

42
Planned Transition to Personalized Health Care
43
  • To visit the Marshfield Clinic, a longtime
    innovator in health information technology, is to
    glimpse medicines digital future. Across the
    national spectrum of health care politics there
    is broad agreement that moving patient records
    into the computer age, the way Marshfield and
    some other health systems have already done, is
    essential to improving care and curbing costs.

By Steve Lohr Published December 26, 2008
44
Biomedical Informatics Research Center (BIRC)
  • Organizational Structure
  • Administrative Informatics Support
  • Biostatistics
  • Usability/ICDI (Interactive Clinical Design
    Institute)
  • Informatics Research
  • Infrastructure Central Resource
  • Research Data Analytics Management
  • Established in 2005
  • 7 PhDs and 38 other staff
  • Mission to accelerate improvements in human
    health and well being through informatics
    research while providing integrated tools,
    services and reliable management of information
    assets in support of Marshfield Clinic missions

45
BIRC Multiple Missions
External Funders
Research Outcomes
BIRC
Design Data Analysis
Strategy Prototyping Evaluation
Researchers
Clinic IS
IT Planning Infrastructure Backoffice
Foundation Administration
46
BIRC Personnel Growth
Does not include short term students
46
47
BIRC Expansion
  • Cost 980,000
  • Accommodates 25 additional people in BIRC,
    increasing its staff to 65
    by end FY 2012
  • Provides enhanced Biomedical informatics
    infrastructure support for increased
    collaboration with internal external
    investigators
  • BIRC expansion will house personnel to support
  • MCRFs new tenure track hires grants they will
    generate
  • Collaboration w/ MCs IS (RD usability,
    decision support, etc.)
  • New Networks in Personalized Care and Population
    Research
  • Dental Informatics Oral Systemic Health
    Research Networks

48
Dental Informatics Research
  • It is a sub-discipline of biomedical informatics.
  • Dental informatics is the application of computer
    and information science to improve dental
    practice, research, education and management.
  • Eisner J. The future of dental
    informatics. Eur J Dent Educ. 19993 Suppl
    161-9.

49
Major Dental Informatics Research Projects
  • A Standard Information Model for General Dental
    Records
  • - Funded by National Institute of Dental and
    Craniofacial Research, NIH
  • - Goal is to develop a comprehensive,
    consensus-based Electronic Dental Record
    Information Model (EDRIM) as a reference standard
    for the content and structure of Electronic
    Dental Records
  • Multi-institutional Consortium for Comparative
    Effectiveness Research in Diabetes Treatment and
    Prevention
  • - Funded by Agency for Healthcare Research and
    Quality, DHHS
  • - Goal is to build a national research network
    and a multi-system distributed database for
    conducting comparative effectiveness research
    (CER) in the treatment and prevention of diabetes
    mellitus
  • Personnel Dr. Amit Acharya
  • Collaboration University of Pittsburgh

50
Objectives Purpose of Forum
  • Provide an opportunity for research networks and
    other research groups to learn about each other
    and the projects they conduct.
  • Learn about operational and project barriers, and
    successful methods to overcome barriers.
  • Facilitate networking and connections between
    people and groups with similar interests.
Write a Comment
User Comments (0)
About PowerShow.com